Paul Tudor Jones's RMD Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 1,796 shares of ResMed Inc. (RMD) worth $403,166, representing 0.00% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 44 quarters.
Based on 13F filings since 2013, Paul Tudor Jones has maintained a long-term strategic position in RMD, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2023, adding 123,580 shares. Largest reduction occurred in Q3 2024, reducing 114,586 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's ResMed (RMD) Holding Value Over Time
Track share changes against reported price movement
Quarterly ResMed (RMD) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +1,796 | New Buy | 1,796 | $224.48 |
| Q3 2025 | -15,596 | Sold Out | 0 | $0.00 |
| Q2 2025 | +15,596 | New Buy | 15,596 | $258.00 |
| Q1 2025 | -7,724 | Sold Out | 0 | $0.00 |
| Q4 2024 | +6,364 | Add 467.94% | 7,724 | $228.69 |
| Q3 2024 | -114,586 | Reduce 98.83% | 1,360 | $244.12 |
| Q2 2024 | -55,132 | Reduce 32.23% | 115,946 | $191.42 |
| Q1 2024 | +47,498 | Add 38.44% | 171,078 | $198.03 |
| Q4 2023 | +123,580 | New Buy | 123,580 | $172.02 |
| Q3 2023 | -17,259 | Sold Out | 0 | $0.00 |
| Q2 2023 | -34,140 | Reduce 66.42% | 17,259 | $218.50 |
| Q1 2023 | +25,062 | Add 95.16% | 51,399 | $0.22 |
| Q4 2022 | +22,846 | Add 654.43% | 26,337 | $0.21 |
| Q3 2022 | +3,491 | New Buy | 3,491 | $218.28 |
| Q4 2021 | -1,413 | Sold Out | 0 | $0.00 |
| Q3 2021 | +1,413 | New Buy | 1,413 | $263.27 |
| Q4 2020 | -2,498 | Sold Out | 0 | $0.00 |
| Q3 2020 | +2,498 | New Buy | 2,498 | $171.34 |
| Q2 2020 | -2,819 | Sold Out | 0 | $0.00 |
| Q1 2020 | +2,819 | New Buy | 2,819 | $147.22 |
| Q2 2019 | -7,959 | Sold Out | 0 | $0.00 |
| Q1 2019 | +7,959 | New Buy | 7,959 | $103.91 |
| Q4 2018 | -20,617 | Sold Out | 0 | $0.00 |
| Q3 2018 | -2,125 | Reduce 9.34% | 20,617 | $115.34 |
| Q2 2018 | +22,742 | New Buy | 22,742 | $103.60 |
| Q1 2018 | -4,377 | Sold Out | 0 | $0.00 |
| Q4 2017 | +4,377 | New Buy | 4,377 | $84.76 |
| Q3 2017 | -7,983 | Sold Out | 0 | $0.00 |
| Q2 2017 | -16,512 | Reduce 67.41% | 7,983 | $77.92 |
| Q1 2017 | +24,495 | New Buy | 24,495 | $71.97 |
| Q4 2016 | -17,487 | Sold Out | 0 | $0.00 |
| Q3 2016 | +9,242 | Add 112.09% | 17,487 | $64.79 |
| Q2 2016 | -9,586 | Reduce 53.76% | 8,245 | $63.19 |
| Q1 2016 | +8,731 | Add 95.95% | 17,831 | $57.82 |
| Q4 2015 | +9,100 | New Buy | 9,100 | $53.74 |
| Q3 2015 | -6,500 | Sold Out | 0 | $0.00 |
| Q2 2015 | +6,500 | New Buy | 6,500 | $56.31 |
| Q1 2015 | -5,100 | Sold Out | 0 | $0.00 |
| Q4 2014 | +5,100 | New Buy | 5,100 | $56.08 |
| Q2 2014 | -10,683 | Sold Out | 0 | $0.00 |
| Q1 2014 | -6,336 | Reduce 37.23% | 10,683 | $44.65 |
| Q4 2013 | +17,019 | New Buy | 17,019 | $47.07 |
| Q3 2013 | -8,000 | Sold Out | 0 | $0.00 |
| Q2 2013 | +8,000 | Add 0.00% | 8,000 | $45.12 |
Paul Tudor Jones's ResMed Investment FAQs
Paul Tudor Jones first purchased ResMed Inc. (RMD) in Q2 2013, acquiring 8,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held ResMed Inc. (RMD) for 44 quarters since Q2 2013.
Paul Tudor Jones's largest addition to ResMed Inc. (RMD) was in Q4 2023, adding 123,580 shares worth $21.26 M.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 1,796 shares of ResMed Inc. (RMD), valued at approximately $403,166.
As of the Q1 2026 filing, ResMed Inc. (RMD) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in ResMed Inc. (RMD) was 171,078 shares, as reported at the end of Q1 2024.